Stay updated on IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Sign up to get notified when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.

Latest updates to the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check7 days agoChange DetectedThe study record area now displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previously visible study content. This blocks access to the trial details and related information on the page, reflecting an access restriction at the site level.SummaryDifference18%

- Check43 days agoChange DetectedThe page shows a new Revision: v3.6.6 tag replacing the previous v3.6.5, indicating a software build update. This change affects only the page's version label and does not alter study information or navigation.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Revision: v3.6.5 label was added and the old Revision: v3.6.4 label was removed, signaling a platform update. The change does not affect the study content or page navigation.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new build of the page. There are no visible changes to study details or content.SummaryDifference0.0%

Stay in the know with updates to IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.